Telix Pharmaceuticals Forms Strategic Theranostics Research Partnership with United Imaging Healthcare
Telix Pharmaceuticals (NASDAQ:TLX) has entered into a strategic research collaboration with United Imaging Healthcare to advance integrated theranostics. The partnership aims to combine Telix's molecular imaging products and clinical protocols with United Imaging’s advanced scanner platforms, software, and AI capabilities.
Topics: Cancer Care Imaging Technology Pharmaceuticals Theranostics